MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
PerkinElmer ROA Ratio 2011-2026 | PKI
Annual ROA Ratio PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.98 | 2.18 | 5.11 | 6.29 | 1.6 | - | 3.48 | 3.98 | 5.48 | 5.1 | - | 3.82 | 4.24 | 0.2 | 11.96 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.96 | 0.2 | 4.26 |
Quarterly ROA Ratio PerkinElmer
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.9 | 2.26 | 2.23 | 1.35 | 1.42 | 0.75 | 0.59 | 4.21 | 4.83 | 5.38 | 6.39 | 3.07 | 7.85 | 8.09 | 9.64 | 12.78 | 10.57 | 12.29 | 11.54 | 5.17 | 6.15 | 4.48 | 3.47 | 3.48 | 3.69 | 4.07 | 4.09 | 3.98 | 2.11 | 2.33 | 4.61 | 4.8 | 7.12 | 6.97 | 5.14 | 5.64 | 5.36 | 5.37 | 5.05 | 3.56 | 4.31 | 3.97 | 3.99 | 3.82 | 4.77 | 4.76 | 4.25 | 4.24 | 2.14 | 1.88 | 2.03 | 1.79 | 11.33 | 11.65 | 11.61 | 11.79 | 1.08 | 0.83 | 0.75 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.78 | 0.59 | 5.0 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
11.3 | $ 116.77 | 2.54 % | $ 35.5 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.19 | 1.71 % | $ 6.48 M | USA |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 24.96 | 0.52 % | $ 693 M | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 15.9 | -0.06 % | $ 481 M | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Danaher Corporation
DHR
|
4.33 | $ 196.79 | 3.03 % | $ 140 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.91 | -4.44 % | $ 8.45 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 128.88 | 1.93 % | $ 20.5 B | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 17.85 | 1.02 % | $ 951 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
-20.67 | $ 93.45 | 0.16 % | $ 11.7 B | USA |
 |
DexCom
DXCM
|
13.19 | $ 65.61 | 3.96 % | $ 25.6 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 275.56 | 2.37 % | $ 22.9 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 80.03 | 2.5 % | $ 5.4 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 15.99 | -0.62 % | $ 172 M |  China |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 324.02 | 4.25 % | $ 27.3 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 108.01 | 0.79 % | $ 8.91 B |  Irlanda |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.75 | 0.11 % | $ 440 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 212.17 | 1.38 % | $ 20.9 B | USA |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.46 | 1.04 % | $ 438 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 27.99 | 3.63 % | $ 20 B |  Niderland |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Personalis
PSNL
|
-30.08 | $ 6.41 | 3.89 % | $ 380 M | USA |
 |
RadNet
RDNT
|
-0.5 | $ 56.08 | 2.75 % | $ 4.22 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 175.71 | 3.64 % | $ 8.71 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K |  Israel |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.6 | -2.37 % | $ 275 M | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 503.51 | 2.88 % | $ 190 B | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 51.68 | 3.11 % | $ 3.09 B | USA |
 |
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
-1.7 | $ 27.98 | -1.82 % | $ 44.9 M | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 320.56 | 4.29 % | $ 19.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Exagen
XGN
|
-34.39 | $ 3.08 | 2.5 % | $ 66.4 M | USA |